Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Zubsolv

Generic name: Buprenorphine and naloxone

FDA application holder: Edenbridge Pharms

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Zubsolv?
Zubsolv is a brand name of Buprenorphine and naloxone, a prescription medicine. The FDA NDC Directory lists 12 Zubsolv products in 6 strengths and forms.
Who makes Zubsolv?
Edenbridge Pharms holds the FDA application for Zubsolv (NDA204242, approved July 3, 2013). 1 other company (repackagers or distributors) also list Zubsolv products.
Is there a generic or store brand of Zubsolv?
Other products of Buprenorphine and naloxone are listed with the FDA, but none in exactly the same strength and form as a Zubsolv product.
What do pharmacies pay for Zubsolv?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 6 Zubsolv strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Zubsolv been recalled?
No recall linked to Zubsolv products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Zubsolv is

Each Zubsolv product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Buprenorphine and naloxone · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
buprenorphine hydrochloride 0.7 mg · naloxone hydrochloride 0.18 mg
tablet, orally disintegrating (sublingual)
Zubsolv None listed DailyMed
buprenorphine hydrochloride 1.4 mg · naloxone hydrochloride 0.36 mg
tablet, orally disintegrating (sublingual)
Zubsolv None listed DailyMed
buprenorphine hydrochloride 11.4 mg · naloxone hydrochloride 2.9 mg
tablet, orally disintegrating (sublingual)
Zubsolv None listed DailyMed
buprenorphine hydrochloride 2.9 mg · naloxone hydrochloride 0.71 mg
tablet, orally disintegrating (sublingual)
Zubsolv None listed DailyMed
buprenorphine hydrochloride 5.7 mg · naloxone hydrochloride 1.4 mg
tablet, orally disintegrating (sublingual)
Zubsolv None listed DailyMed
buprenorphine hydrochloride 8.6 mg · naloxone hydrochloride 2.1 mg
tablet, orally disintegrating (sublingual)
Zubsolv None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Buprenorphine and naloxone →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Zubsolv products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA204242Edenbridge PharmsJuly 3, 201312

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Zubsolv, by strength and form
Strength and formGeneric or brandPharmacies pay
buprenorphine hydrochloride 0.7 mg · naloxone hydrochloride 0.18 mg
tablet, orally disintegrating
Brand: Zubsolv $5.26 per tablet
buprenorphine hydrochloride 1.4 mg · naloxone hydrochloride 0.36 mg
tablet, orally disintegrating
Brand: Zubsolv $5.26 per tablet
buprenorphine hydrochloride 11.4 mg · naloxone hydrochloride 2.9 mg
tablet, orally disintegrating
Brand: Zubsolv $21.05 per tablet
buprenorphine hydrochloride 2.9 mg · naloxone hydrochloride 0.71 mg
tablet, orally disintegrating
Brand: Zubsolv $10.52 per tablet
buprenorphine hydrochloride 5.7 mg · naloxone hydrochloride 1.4 mg
tablet, orally disintegrating
Brand: Zubsolv $10.54 per tablet
buprenorphine hydrochloride 8.6 mg · naloxone hydrochloride 2.1 mg
tablet, orally disintegrating
Brand: Zubsolv $15.81 per tablet

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Zubsolv

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Zubsolv products.

Recalls

No recall linked to Zubsolv products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers